Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 4.1% - Here's What Happened

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was down 4.1% during mid-day trading on Monday . The company traded as low as $7.50 and last traded at $7.55. Approximately 93,530 shares traded hands during trading, a decline of 88% from the average daily volume of 784,465 shares. The stock had previously closed at $7.87.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on BAYRY shares. Hsbc Global Res upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Wednesday, June 11th. Wall Street Zen raised Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Thursday. The Goldman Sachs Group raised Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Finally, Kepler Capital Markets raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Wednesday, June 11th. One equities research analyst has rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Bayer Aktiengesellschaft has a consensus rating of "Buy".

Bayer Aktiengesellschaft Price Performance

The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.07. The company's 50 day moving average price is $7.06 and its 200 day moving average price is $6.15. The company has a market cap of $29.55 billion, a price-to-earnings ratio of -8.17 and a beta of 0.85.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.02. Bayer Aktiengesellschaft had a negative net margin of 7.26% and a positive return on equity of 13.94%. The business had revenue of $15.27 billion during the quarter, compared to the consensus estimate of $13.39 billion. Equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

Bayer Aktiengesellschaft Increases Dividend

The firm also recently disclosed a dividend, which was paid on Monday, May 12th. Investors of record on Wednesday, April 30th were given a $0.0224 dividend. The ex-dividend date was Tuesday, April 29th. This is a positive change from Bayer Aktiengesellschaft's previous dividend of $0.02. This represents a dividend yield of 0.38%. Bayer Aktiengesellschaft's payout ratio is currently -2.17%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.